Abiopharma

🔍 RAGSDALE BRUCE (Executive)

Company: ICHOR HOLDINGS, LTD. (ICHR)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 6,456 shares of Ordinary Shares, par value $0.0001 at $51.74 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 96,455.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,931 shares of Ordinary Shares, par value $0.0001 at $52.19 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,524.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 200 shares of Ordinary Shares, par value $0.0001 at $53.05 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,324.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents number of shares sold under a Rule 10b5-1 Trading Plan adopted by Mr. Ragsdale on June 2, 2026.
• F2: The reported price is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $51.05 to $52.04 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.
• F3: The reported price is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $52.05 to $52.63 per share.